
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Tetrahydrobiopterin (BH4) is an essential cofactor for aromatic amino acid hydroxylases that synthesize neurotransmitters dopamine, serotonin, and norepinephrine. BH4 also serves as a cofactor for nitric oxide synthase, supporting cardiovascular function through enhanced nitric oxide production.

Reported Benefits (Provisional)
Origin & History

Tetrahydrobiopterin (BH4) is a naturally occurring cofactor found in the body, essential for the synthesis of neurotransmitters. It is synthesized from guanosine triphosphate (GTP) in a multi-step process. BH4 is often produced synthetically for supplementation purposes.
Research Narrative (Provisional)
Several RCTs and observational studies have explored BH4's role in neurotransmitter synthesis and cardiovascular health. Meta-analyses suggest potential benefits in managing phenylketonuria and certain mood disorders.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Acts as a cofactor for phenylalanine, tyrosine, and tryptophan hydroxylases. - Involved in the production of serotonin, dopamine, and norepinephrine. - Plays a role in nitric oxide synthase activity.
Reported Mechanism (Provisional)
BH4 acts as an essential cofactor for phenylalanine hydroxylase, tyrosine hydroxylase, and tryptophan hydroxylase, enabling the conversion of amino acids to neurotransmitter precursors L-DOPA and 5-HTP. It also functions as a cofactor for all three nitric oxide synthase isoforms (eNOS, nNOS, iNOS), facilitating the conversion of L-arginine to nitric oxide and L-citrulline. BH4 deficiency can lead to eNOS uncoupling, resulting in superoxide production instead of beneficial nitric oxide.
Clinical Narrative (Provisional)
Clinical studies on BH4 supplementation are limited primarily to genetic BH4 deficiency disorders and endothelial dysfunction research. A study of 20 patients with BH4 deficiency showed significant improvements in neurological symptoms with sapropterin dihydrochloride supplementation. Small trials in cardiovascular disease patients (n=15-30) demonstrated improved endothelial function and flow-mediated dilation with BH4 administration. Evidence for cognitive or mood benefits in healthy populations remains preliminary and requires larger controlled trials.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







